Livestock diseases such as BSE, avian influenza and foot-and-mouth disease
First written in FY2017-Q1. 5 of 8 entries say "Restated". Latest entry: FY2023.
The whole theme swung hardest in 2025: 24 of 33 companies on the "Worse" side.
24 other companies' latest entry also says "Restated".
- FY2023RestatedAnnual report
「If livestock diseases such as ASF (African swine fever), avian influenza and BSE (bovine spongiform encephalopathy) spread」
Continues to describe the risk of impacts on procurement and sales from livestock diseases such as ASF, avian influenza and BSE, along with response manuals. - FY2022RestatedAnnual report
「If livestock diseases such as ASF (African swine fever), avian influenza and BSE (bovine spongiform encephalopathy) spread」
Continues to identify the impact of livestock diseases such as ASF, avian influenza and BSE on procurement and sales as a significant risk, and indicates that response manuals are being developed. - FY2020WorsenedAnnual report
「However, if livestock diseases such as African swine fever (ASF), avian influenza and BSE (bovine spongiform encephalopathy) spread, domestic and overseas meat prices could fluctuate substantially, disrupting the procurement and sale of meat and potentially affecting the Group's operating performance.」
Expands the scope of the livestock disease risk by explicitly adding ASF (African swine fever) to the previously identified risks such as BSE and avian influenza. - FY2018RestatedAnnual report
「The occurrence of livestock diseases such as BSE, avian influenza, foot-and-mouth disease and porcine epidemic diarrhea, or the activation of safeguards covering imported pork and beef, could restrict procurement volumes and increase procurement prices.」
Continues to describe the risk of procurement and price impacts from livestock diseases such as BSE, avian influenza, foot-and-mouth disease and PED, as well as safeguards. - FY2017WorsenedAnnual report
「The activation of safeguards covering imported pork and beef, and the occurrence of livestock diseases such as BSE, porcine epidemic diarrhea (PED), avian influenza and foot-and-mouth disease, could affect the Group's operating performance.」
Explicitly adds porcine epidemic diarrhea (PED) to the previously identified livestock disease risks. - FY2017-Q3RestatedAnnual report
「The occurrence in these regions of livestock diseases such as BSE, avian influenza and foot-and-mouth disease could adversely affect the supply of raw materials and sales of the Company's products, and could adversely affect the Group's operating performance and financial position.」
Reiterates the risk that livestock diseases could affect raw material supplies and sales. - FY2017-Q2RestatedAnnual report
「The occurrence in these regions of livestock diseases such as BSE, avian influenza and foot-and-mouth disease could adversely affect the supply of raw materials and sales of the Company's products, and could adversely affect the Group's operating performance and financial position.」
Reiterates the risk that livestock diseases could affect raw material supplies and sales. - FY2017-Q1First statedAnnual report
「The occurrence in these regions of livestock diseases such as BSE, avian influenza and foot-and-mouth disease could adversely affect the supply of raw materials and sales of the Company's products, and could adversely affect the Group's operating performance and financial position.」
Identifies the impact of livestock diseases in Japan and overseas on raw material supplies and product sales as a risk.